WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

The expansion was driven by lower priced items, including diabetic drugs and vitamins. “During the quarter under review, the ...

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

With Donald Trump securing a second presidential term, what issues should be top of mind for the pharmaceutical sector in the ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The government's new Rs 500 crore scheme for the medical device industry will not only boost domestic manufacturing but also ...

Through various recent evolutions, the economic situation of the pharmaceutical companies operating in France become increasingly challenging.

The mutual fund expert believes that a strategic allocation of 10-20% in the pharma and healthcare funds could benefit ...

Election Day is just about here, marking an end to the unpredictable ride that has been the 2024 presidential race following ...

In a significant financial move in the pharmaceutical industry, Edwards Life Sciences has sold its Critical Care division to Becton Dickinson (BD) for $4,200 million. The transaction, legally executed ...